论文部分内容阅读
目的:研究胃癌术后腹腔热灌注化疗联合静脉化疗临床疗效。方法:116例胃癌术后患者随机分为腹腔热灌注组和静脉化疗组,腹腔热灌注组在静脉化疗同时应用腹腔热灌注化疗,观察两组术后生存率、并发症、不良反应及腹腔复发率。结果:两组术后并发症及不良反应无统计学差异,术后3a、5a生存率和复发率有统计学差异。结论:胃癌术后腹腔热灌注联合静脉化疗可有效控制复发和转移,提高胃癌术后患者生存率和生存质量。
Objective: To study the clinical effects of intraperitoneal hyperthermic perfusion chemotherapy combined with intravenous chemotherapy after gastric cancer surgery. Methods: One hundred and sixteen patients with gastric cancer were randomly divided into intraperitoneal hyperthermic perfusion group and intravenous chemotherapy group. The intraperitoneal hyperthermic perfusion group was treated with intraperitoneal hyperthermic perfusion chemotherapy simultaneously. The postoperative survival rate, complications, adverse reactions and peritoneal recurrence rate. Results: There was no significant difference in postoperative complications and adverse reactions between the two groups. The postoperative survival rates and recurrence rates of 3a and 5a were statistically different. Conclusions: Intraperitoneal hyperthermic perfusion combined with intravenous chemotherapy can effectively control recurrence and metastasis of gastric cancer and improve the survival rate and quality of life of postoperative patients with gastric cancer.